Marit Austgulen Wick
Direttore Finanziario/CFO presso Sarsia Venture Management AS
Profilo
Marit Austgulen Wick currently works at Gulen & Masfjorden Utvikling AS, as Director, Sarsia Venture Management AS, as Chief Financial Officer from 2005, and Sarsia Seed Management AS, as Partner & Chief Financial Officer from 2016.
Ms. Wick also formerly worked at Rieber & Son AS, as Accounting Director, NORDA ASA, as Chief Financial Officer, Colon AS, as Chief Financial Officer, Novel Diagnostics AS, as Chief Executive & Financial Officer, ScreenCancer AS, as Chief Financial Officer, and BerGenBio ASA, as Chief Financial Officer.
Ms. Wick received her graduate degree from Norwegian School of Economics & Business Administration.
Posizioni attive di Marit Austgulen Wick
Società | Posizione | Inizio |
---|---|---|
Sarsia Venture Management AS
Sarsia Venture Management AS Investment ManagersFinance Sarsia Venture Management AS (SVM) is a venture capital advisory and management firm based in Bergen, Norway. They manage and advise the Sarsia Life Science Fund, established in 2005, which focuses on life science and biotechnology opportunities in the Nordic region. | Direttore Finanziario/CFO | 05/09/2005 |
Gulen & Masfjorden Utvikling AS | Direttore/Membro del Consiglio | - |
Sarsia Seed Management AS
Sarsia Seed Management AS Investment ManagersFinance Sarsia Seed Management AS is a venture capital firm headquartered in Bergen, Norway. The company was founded in 2006. | Direttore Finanziario/CFO | 01/01/2016 |
Precedenti posizioni note di Marit Austgulen Wick
Società | Posizione | Fine |
---|---|---|
Colon AS | Direttore Finanziario/CFO | - |
BERGENBIO ASA | Direttore Finanziario/CFO | - |
Rieber & Son AS
Rieber & Son AS Food: Major DiversifiedConsumer Non-Durables Rieber & Son AS produces exports and supplies food products to the food service market and other food manufacturers. Its brands include Toro, Vitana, Delecta, Denja, Vetslands Lefsa, Mr. Lee, and Vossafår. Its business units are divided into three segments which reflect the main markets in which it operates. The operating segments are Western Europe, Central Europe and Russia/Others. The Western Europe segment comprises Norway, Denmark, Sweden, Germany, Benelux, the United States of America and the United Kingdom. The Central Europe segment is composed of Czech Republic, Slovakia and Poland. The Russia/Other segment produce and sell nuts in the market. The company was founded by Paul Gottlieb Rieber in 1839 and is headquartered in Bergen, Norway. | Comptroller/Controller/Auditor | - |
NORDA ASA | Direttore Finanziario/CFO | - |
Novel Diagnostics AS
Novel Diagnostics AS BiotechnologyHealth Technology Novel Diagnostics AS provides biomedical research and diagnostics development services. It sells and develops medical and diagnostic products and drives commercialization of research results. The firm also invests in securities; either in form of follow-up investments in companies already has invested in, or as part of other strategic investments. The company was founded on June 10, 2002 and is headquartered in Bergen, Norway. | Amministratore Delegato | - |
Formazione di Marit Austgulen Wick
Norwegian School of Economics & Business Administration | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
NORDA ASA | Commercial Services |
BERGENBIO ASA | Health Technology |
Aziende private | 7 |
---|---|
Rieber & Son AS
Rieber & Son AS Food: Major DiversifiedConsumer Non-Durables Rieber & Son AS produces exports and supplies food products to the food service market and other food manufacturers. Its brands include Toro, Vitana, Delecta, Denja, Vetslands Lefsa, Mr. Lee, and Vossafår. Its business units are divided into three segments which reflect the main markets in which it operates. The operating segments are Western Europe, Central Europe and Russia/Others. The Western Europe segment comprises Norway, Denmark, Sweden, Germany, Benelux, the United States of America and the United Kingdom. The Central Europe segment is composed of Czech Republic, Slovakia and Poland. The Russia/Other segment produce and sell nuts in the market. The company was founded by Paul Gottlieb Rieber in 1839 and is headquartered in Bergen, Norway. | Consumer Non-Durables |
Colon AS | |
Novel Diagnostics AS
Novel Diagnostics AS BiotechnologyHealth Technology Novel Diagnostics AS provides biomedical research and diagnostics development services. It sells and develops medical and diagnostic products and drives commercialization of research results. The firm also invests in securities; either in form of follow-up investments in companies already has invested in, or as part of other strategic investments. The company was founded on June 10, 2002 and is headquartered in Bergen, Norway. | Health Technology |
Sarsia Venture Management AS
Sarsia Venture Management AS Investment ManagersFinance Sarsia Venture Management AS (SVM) is a venture capital advisory and management firm based in Bergen, Norway. They manage and advise the Sarsia Life Science Fund, established in 2005, which focuses on life science and biotechnology opportunities in the Nordic region. | Finance |
Sarsia Seed Management AS
Sarsia Seed Management AS Investment ManagersFinance Sarsia Seed Management AS is a venture capital firm headquartered in Bergen, Norway. The company was founded in 2006. | Finance |
ScreenCancer AS
ScreenCancer AS Medical/Nursing ServicesHealth Services ScreenCancer AS offers cancer screening and diagnostic program to the public. It provides a panel of screening tests for several major cancers such as colorectal, bladder, breast, prostate, skin, and lung. The company was founded by Christian Horn and Dagfinn Steinar Ogreid in 2007 and is headquartered in Sola, Norway. | Health Services |
Gulen & Masfjorden Utvikling AS |
- Borsa valori
- Insiders
- Marit Austgulen Wick